BRIEF-Contravir’S Cyclophilin inhibitor CRV431 targets hepatitis B surface antigen (HBSAG) By: Reuters: Company News April 04, 2017 at 06:11 AM EDT * Contravir’S Cyclophilin inhibitor CRV431 targets hepatitis B surface antigen (HBSAG) Read More >>